Figlin RA - Search Results

1

Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma.

Motzer RJ, Hutson TE, Tomczak P, Michaelson MD, Bukowski RM, Oudard S, Negrier S, Szczylik C, Pili R, Bjarnason GA, Garcia-del-Muro X, Sosman JA, Solska E, Wilding G, Thompson JA, Kim ST, Chen I, Huang X, Figlin RA. Motzer RJ, et al. Among authors: figlin ra. J Clin Oncol. 2009 Aug 1;27(22):3584-90. doi: 10.1200/JCO.2008.20.1293. Epub 2009 Jun 1. J Clin Oncol. 2009. PMID: 19487381 Free PMC article. Corrected and republished. Clinical Trial.

2

Concomitant administration of recombinant human interleukin-2 and recombinant interferon alfa-2A: an active outpatient regimen in metastatic renal cell carcinoma.

Figlin RA, Belldegrun A, Moldawer N, Zeffren J, deKernion J. Figlin RA, et al. J Clin Oncol. 1992 Mar;10(3):414-21. doi: 10.1200/JCO.1992.10.3.414. J Clin Oncol. 1992. PMID: 1482425 Clinical Trial.

3

Intrapleural cisplatin and cytarabine in the management of malignant pleural effusions: a Lung Cancer Study Group trial.

Rusch VW, Figlin R, Godwin D, Piantadosi S. Rusch VW, et al. J Clin Oncol. 1991 Feb;9(2):313-9. doi: 10.1200/JCO.1991.9.2.313. J Clin Oncol. 1991. PMID: 1988578 Clinical Trial.

4

Recombinant interferon alfa-2a in metastatic renal cell carcinoma: assessment of antitumor activity and anti-interferon antibody formation.

Figlin RA, deKernion JB, Mukamel E, Palleroni AV, Itri LM, Sarna GP. Figlin RA, et al. J Clin Oncol. 1988 Oct;6(10):1604-10. doi: 10.1200/JCO.1988.6.10.1604. J Clin Oncol. 1988. PMID: 3049952

5

Subcutaneous interleukin-2 plus interferon alfa-2a in metastatic renal cancer: an outpatient multicenter trial.

Vogelzang NJ, Lipton A, Figlin RA. Vogelzang NJ, et al. Among authors: figlin ra. J Clin Oncol. 1993 Sep;11(9):1809-16. doi: 10.1200/JCO.1993.11.9.1809. J Clin Oncol. 1993. PMID: 8355047 Clinical Trial.

6

Erythropoietin production. A potential marker for interleukin-2/interferon-responsive tumors.

Janik JE, Sznol M, Urba WJ, Figlin R, Bukowski RM, Fyfe G, Pierce WC, Belldegrun A, Sharfman WH, Smith JW 2nd, et al. Janik JE, et al. Cancer. 1993 Nov 1;72(9):2656-9. doi: 10.1002/1097-0142(19931101)72:9<2656::aid-cncr2820720922>3.0.co;2-a. Cancer. 1993. PMID: 8402486

7

Phase III randomized study to compare interferon alfa-2a in combination with fluorouracil versus fluorouracil alone in patients with advanced colorectal cancer.

Greco FA, Figlin R, York M, Einhorn L, Schilsky R, Marshall EM, Buys SS, Froimtchuk MJ, Schuller J, Schuchter L, Buyse M, Ritter L, Man A, Yap AK. Greco FA, et al. J Clin Oncol. 1996 Oct;14(10):2674-81. doi: 10.1200/JCO.1996.14.10.2674. J Clin Oncol. 1996. PMID: 8874326 Clinical Trial.

8

Cytoreductive surgery in the management of metastatic renal cell carcinoma: the UCLA experience.

Franklin JR, Figlin R, Rauch J, Gitlitz B, Belldegrun A. Franklin JR, et al. Semin Urol Oncol. 1996 Nov;14(4):230-6. Semin Urol Oncol. 1996. PMID: 8946623

9

Sarcomatoid renal cell carcinoma: biologic behavior, prognosis, and response to combined surgical resection and immunotherapy.

Cangiano T, Liao J, Naitoh J, Dorey F, Figlin R, Belldegrun A. Cangiano T, et al. J Clin Oncol. 1999 Feb;17(2):523-8. doi: 10.1200/JCO.1999.17.2.523. J Clin Oncol. 1999. PMID: 10080595

10

Multicenter, randomized, phase III trial of CD8(+) tumor-infiltrating lymphocytes in combination with recombinant interleukin-2 in metastatic renal cell carcinoma.

Figlin RA, Thompson JA, Bukowski RM, Vogelzang NJ, Novick AC, Lange P, Steinberg GD, Belldegrun AS. Figlin RA, et al. J Clin Oncol. 1999 Aug;17(8):2521-9. doi: 10.1200/JCO.1999.17.8.2521. J Clin Oncol. 1999. PMID: 10561318 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

381 results

Search Page